Skip to content

Drug interactions

Givinostat + Ipratropium-salbutamol

Severity: Moderate

Givinostat and Ipratropium-salbutamol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Givinostat can prolong the QT interval, and salbutamol may add to this effect, especially with hypokalemia. The givinostat label advises caution with other QT-prolonging drugs.

What this interaction means in plain words

Givinostat and Ipratropium-salbutamol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Givinostat belongs to Miscellaneous; Ipratropium-salbutamol belongs to Respiratory.

Evidence level: Low

Why it happens

Additive QT prolongation, with beta-agonist-induced hypokalemia.

What to do

Obtain an ECG at baseline and during co-use, and correct electrolytes. Withhold givinostat if the QTc exceeds 500 ms or rises more than 60 ms from baseline.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Givinostat and Ipratropium-salbutamol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Givinostat with Ipratropium-salbutamol?

MediHelp rates the interaction as moderate. Givinostat and Ipratropium-salbutamol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Givinostat can prolong the QT interval, and salbutamol may add to this effect, especially with hypokalemia. The givinostat label advises caution with other QT-prolonging drugs.

How serious is the interaction between Givinostat and Ipratropium-salbutamol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain an ECG at baseline and during co-use, and correct electrolytes. Withhold givinostat if the QTc exceeds 500 ms or rises more than 60 ms from baseline.

What other medicines interact with Ipratropium-salbutamol?

MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in